"alpha-Fetoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life.
Descriptor ID |
D000509
|
MeSH Number(s) |
D12.776.124.790.106.092 D12.776.320.525.500 D12.776.377.228.500 D12.776.377.715.085.092 D23.101.140.050
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "alpha-Fetoproteins".
Below are MeSH descriptors whose meaning is more specific than "alpha-Fetoproteins".
This graph shows the total number of publications written about "alpha-Fetoproteins" by people in this website by year, and whether "alpha-Fetoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 1 | 1 | 2 |
1997 | 0 | 4 | 4 |
1998 | 2 | 1 | 3 |
1999 | 2 | 3 | 5 |
2000 | 2 | 1 | 3 |
2001 | 0 | 1 | 1 |
2002 | 0 | 2 | 2 |
2003 | 0 | 4 | 4 |
2004 | 1 | 3 | 4 |
2005 | 4 | 3 | 7 |
2006 | 1 | 2 | 3 |
2007 | 0 | 2 | 2 |
2008 | 2 | 3 | 5 |
2009 | 2 | 3 | 5 |
2010 | 2 | 6 | 8 |
2011 | 3 | 4 | 7 |
2012 | 0 | 3 | 3 |
2013 | 1 | 3 | 4 |
2014 | 3 | 2 | 5 |
2015 | 5 | 1 | 6 |
2016 | 0 | 8 | 8 |
2017 | 0 | 1 | 1 |
2018 | 2 | 1 | 3 |
2019 | 0 | 2 | 2 |
2020 | 1 | 1 | 2 |
2021 | 3 | 2 | 5 |
2022 | 0 | 6 | 6 |
2023 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "alpha-Fetoproteins" by people in Profiles.
-
Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma. Mod Pathol. 2024 Feb; 37(2):100385.
-
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass. Oncology (Williston Park). 2023 08 08; 37(8):335-338.
-
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee. Pediatr Blood Cancer. 2023 07; 70(7):e30365.
-
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study. Hepatol Commun. 2023 03 01; 7(3).
-
Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era? J Hepatol. 2023 01; 78(1):207-216.
-
Detecting Early Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Using Longitudinal a-Fetoprotein Screening. Clin Gastroenterol Hepatol. 2023 06; 21(6):1590-1597.
-
DETECT: Development of Technologies for Early HCC Detection. Gastroenterology. 2022 07; 163(1):21-27.
-
Utility of serum angiopoietin-2 as diagnostic marker of hepatocellular carcinoma: A systematic review and diagnostic test accuracy meta-analysis. Clin Res Hepatol Gastroenterol. 2022 05; 46(5):101909.
-
A multivariate parametric empirical Bayes screening approach for early detection of hepatocellular carcinoma using multiple longitudinal biomarkers. Stat Med. 2022 06 15; 41(13):2338-2353.
-
The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States. Clin Gastroenterol Hepatol. 2023 02; 21(2):415-423.e4.